Cambridge Semantics executives will be onsite at booth #129 demonstrating the company’s Competitive Intelligence and Drug Safety & Pharmacovigilance solutions.
Boston, MA (PRWEB) April 02, 2013
Cambridge Semantics will again be a featured presenter at the annual Bio-IT World Conference & Expo. During this month’s event, Cambridge Semantics Vice President of Marketing and Technology, Lee Feigenbaum will speak on a new conference track, “Data Visualization and Exploration” which highlights novel visualization approaches that address important challenges in genomic data, networks, microscopy, imaging and the support of discovery, clinical and translational research. During his session, Mr. Feigenbaum will address Unified Information Access and its role in data exploration and visualization. To learn more visit http://www.bio-itworldexpo.com or visit the Cambridge Semantics booth #129 at the event.
- Date and time: Wednesday, April 10th at 12:00 p.m. EST
- Title: Whence the Data? The Importance of Feeding the Right Data to Your Visualizations
- Session description: Visualizations are only as good as the data that drives them.
Frequently, the right data comes from many and diverse sources. This discussion will present the case for Unified Information Access, a paradigm that lets you easily combine structured and unstructured data from inside and outside your organization in support of ever-evolving data exploration and visualization. Examples will include practical applications for competitive intelligence, safety, and assay data management.
In addition, Cambridge Semantics executives will be onsite at booth #129 demonstrating the company’s Competitive Intelligence and Drug Safety & Pharmacovigilance solutions. At the 2012 Bio-IT World Conference Cambridge Semantics’ Competitive Intelligence Solution was named “Best of Show” for its unique approach to helping pharma companies handle their diverse and ever-changing information needs. The company’s Drug Safety & Pharmacovigilance solution helps pharma reduce operational cost and improve risk management by automating and streamlining the process of discovering, managing, and analyzing adverse drug reactions.
About Cambridge Semantics
Cambridge Semantics provides the award-winning Anzo software suite, an open platform for building interactive Unified Information Access (UIA) solutions. Enterprises face an increasing need to rapidly discover, understand, combine, and act on data from diverse sources both from within and across organizational boundaries. Anzo makes it easy for both IT and end users to deal with this need by rapidly creating solutions that leverage unified access to structured and unstructured data from varied sources in the context of specific business problems.
Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics.